Experts in Biopharmaceutical Manufacturing and Development Biovian to Attend BIO KOREA 2013

Biovian a leading GMP manufacture of biopharmaceuticals have announced it will be exhibiting at the BIO KOREA 2013 International Convention.

The event will be a fantastic opportunity for Biovian’s CEO Dr. Knut Ringbom and Director of Business Development and Projects, Mr. Antti Nieminen to showcase and discuss their expertise in the field of biopharmaceutical manufacturing and development.

BIO KOREA 2013 will be the 8th BIO KOREA taking place and will be held from September 11th – 13th at KINTEX Korea International Exhibition Center.

Attendees are invited to visit Dr. Knut Ringbom and Mr. Antti Nieminen at stand number M20 & M21.

About Biovian
From Gene to Finished vial

Biovian is a one-stop-shop in GMP contract manufacturing of biopharmaceuticals covering services from early development to finished vial. Biovian’s 2300 m2 facilities are EMA and FDA certified for cGMP production of investigational and commercial products.

Biovian GMP services:
• Microbial fermentation
• Mammalian cell culture
• Viral vector production
• Protein purification
• Formulation
• Aseptic Fill & Finish
• Analytical Quality Control Services
• Stability studies
• Master cell banking
• Drug product labelling, packaging, storage and QP release

Biovian development services:
• Cell line Development
• Process Development
• Analytical Development

About BIO KOREA 2013
BIO KOREA was first staged in 2006 and has become an influential annual event in Asia. The event provides a great opportunity for both domestic and foreign investors to meet fast growing Korean bio companies and leading Korean research institutions.

Contact:
Biovian Ltd
Tel: +358 2 27488 77
Email: [email protected]

For more information about Biovian’s biopharmaceutical manufacturing and development services, please contact Biovian directly.